Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...

From vaccination to immunity, here are your questions about measles answered, as Canada continues to see cases rising in 2025 ...

The federal government on Saturday dismissed charges against a Utah plastic surgeon accused of throwing away COVID-19 ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.

A child has died at Alder Hey hospital in Liverpool after contracting measles amid public health warnings about increasing ...

The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...

Alder Hey Children's Hospital in Liverpool said it has treated nearly 20 cases of measles since June, and put the increase ...

Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed dengue vaccine, DengiAll, is likely to be completed by October across 20 ...

A child has died of measles after being treated in intensive care in Liverpool. The child, who was treated at Alder Hey Children’s Hospital, has not been identified. They understood to have been ...

Just a week before clinical trials were set to begin, South African scientists working on a promising HIV vaccine were told to halt all work, as the Trump administration abruptly withdrew $46 million ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...